Total Payments
$87,657
2024 Payments
$11,295
Companies
26
Transactions
168
Medicare Patients
12,026
Medicare Billing
$5.1M
Payment Breakdown by Category
Consulting$52,551 (60.0%)
Other$15,715 (17.9%)
Travel$11,458 (13.1%)
Food & Beverage$7,909 (9.0%)
Education$14.66 (0.0%)
Gifts$10.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $52,551 | 18 | 60.0% |
| Honoraria | $15,215 | 8 | 17.4% |
| Travel and Lodging | $11,458 | 24 | 13.1% |
| Food and Beverage | $7,909 | 115 | 9.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 0.6% |
| Education | $14.66 | 1 | 0.0% |
| Gift | $10.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $25,402 | 22 | $0 (2024) |
| Genentech USA, Inc. | $24,472 | 40 | $0 (2024) |
| Alimera Sciences, Inc. | $20,390 | 30 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $3,669 | 5 | $0 (2019) |
| EyePoint Pharmaceuticals US, Inc. | $3,599 | 5 | $0 (2024) |
| Genentech, Inc. | $1,850 | 2 | $0 (2023) |
| Alcon Research LLC | $1,605 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $1,545 | 1 | $0 (2019) |
| Spark Therapeutics, Inc. | $827.76 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $630.70 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,295 | 43 | Genentech USA, Inc. ($7,043) |
| 2023 | $7,357 | 28 | Alimera Sciences, Inc. ($3,376) |
| 2022 | $22,102 | 39 | Alimera Sciences, Inc. ($9,046) |
| 2021 | $770.40 | 7 | Vertex Pharmaceuticals Incorporated ($508.33) |
| 2020 | $5,883 | 4 | Alcon Vision LLC ($5,870) |
| 2019 | $33,914 | 31 | Alcon Vision LLC ($15,276) |
| 2018 | $6,000 | 11 | Genentech USA, Inc. ($4,881) |
| 2017 | $335.86 | 5 | Mallinckrodt LLC ($168.93) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: OPTOMETRY | ||||||
| 11/19/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $135.25 | General |
| 11/08/2024 | Amgen Inc. | PAVBLU (Biological) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $3,360.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $308.57 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $179.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/05/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/04/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $121.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $2,730.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/20/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Honoraria | Cash or cash equivalent | $1,390.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 08/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/09/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/06/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: EYE CARE | ||||||
| 08/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $148.82 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Ophthalmology | ||||||
| 06/17/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $146.00 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: EYE CARE | ||||||
| 06/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/10/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $95.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/09/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $117.61 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,566 | 38,046 | $7.2M | $2.3M |
| 2022 | 21 | 4,410 | 14,171 | $5.8M | $1.9M |
| 2021 | 17 | 2,948 | 5,510 | $2.2M | $712,191 |
| 2020 | 11 | 1,102 | 2,170 | $1.1M | $222,484 |
Total Patients
12,026
Total Services
59,897
Medicare Billing
$5.1M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 157 | 28,740 | $2.4M | $831,641 | 34.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 126 | 792 | $1.6M | $536,979 | 33.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 128 | 2,341 | $1.4M | $426,048 | 30.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 368 | 1,291 | $780,022 | $118,586 | 15.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 696 | 1,020 | $228,234 | $92,505 | 40.5% |
| 92134 | Imaging of retina | Office | 2023 | 1,206 | 2,736 | $231,567 | $78,933 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 391 | 512 | $101,688 | $46,314 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 180 | 180 | $52,859 | $22,038 | 41.7% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 12 | 110 | $55,000 | $19,454 | 35.4% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 18 | 19 | $69,728 | $16,982 | 24.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 136 | 136 | $36,364 | $14,441 | 39.7% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 12 | 14 | $60,200 | $14,065 | 23.4% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 13 | 13 | $38,164 | $11,622 | 30.5% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 13 | 15 | $32,836 | $9,459 | 28.8% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 18 | 26 | $61,794 | $6,500 | 10.5% |
| 66820 | Removal of recurring cataract in lens capsule by stab incision | Facility | 2023 | 19 | 21 | $15,148 | $3,892 | 25.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 35 | 36 | $6,114 | $3,672 | 60.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,613 | $2,474 | 44.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 12 | 16 | $2,000 | $852.46 | 42.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 11 | 13 | $1,655 | $376.06 | 22.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 219 | 4,132 | $2.5M | $898,234 | 36.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 107 | 687 | $1.3M | $480,794 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 784 | 1,640 | $311,600 | $153,805 | 49.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 365 | 1,178 | $795,600 | $107,136 | 13.5% |
| 92134 | Imaging of retina | Office | 2022 | 1,189 | 2,815 | $234,025 | $78,805 | 33.7% |
About Dr. Athanasios Papakostas, MD
Dr. Athanasios Papakostas, MD is a Ophthalmology healthcare provider based in Brentwood, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1588975346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Athanasios Papakostas, MD has received a total of $87,657 in payments from pharmaceutical and medical device companies, with $11,295 received in 2024. These payments were reported across 168 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($52,551).
As a Medicare-enrolled provider, Papakostas has provided services to 12,026 Medicare beneficiaries, totaling 59,897 services with total Medicare billing of $5.1M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Brentwood, MO
- Active Since 06/27/2010
- Last Updated 09/03/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1588975346
Products in Payments
- Lucentis (Biological) $17,404
- Constellation (Device) $14,657
- ILUVIEN (Drug) $13,812
- Vabysmo (Drug) $7,146
- Iluvien (Drug) $6,339
- ARGOS (Device) $5,600
- ACTHAR (Biological) $3,669
- YUTIQ (Drug) $1,973
- EYP-1901 (Drug) $1,864
- VABYSMO (Drug) $1,760
- Balversa (Drug) $1,545
- LUXTURNA (Biological) $827.76
- Jetrea (Drug) $556.58
- EYLEA (Biological) $487.55
- OZURDEX (Drug) $322.47
- Luxor (Device) $311.21
- EVA, combined machine (Device) $278.57
- NGENUITY (Device) $261.07
- EYLEA HD (Biological) $183.04
- EVA Ophthalmic Surgical System (Device) $168.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Brentwood
Raju Sarwal, Md, MD
Ophthalmology — Payments: $198,307
Ophthalmology $198,307
Dr. James Rynerson, Md, MD
Ophthalmology — Payments: $19,221
Ophthalmology $19,221
Dr. Aaron Avni, Md, MD
Ophthalmology — Payments: $18,274
Ophthalmology $18,274
John Passarelli, Md, MD
Ophthalmology — Payments: $16,459
Ophthalmology $16,459
Dr. Neil Nichols, M.d, M.D
Ophthalmology — Payments: $12,488
Ophthalmology $12,488
Shetal Shah, M.d, M.D
Ophthalmology — Payments: $4,083
Ophthalmology $4,083